Skip to content

Coronary flow reserve to increase diagnostic yield in MINOCA (EDIT-MINOCA): a randomized controlled clinical trial.

Coronary flow reserve to increase diagnostic yield in MINOCA (EDIT-MINOCA): a randomized controlled clinical trial. - EDIT-MINOCA

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57728
Enrollment
160
Registered
2024-12-27
Start date
2026-04-15
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial infarction with nonobstructive coronary arteries (MINOCA) heart infarction with normal coronary arteries

Interventions

160 patients with MINOCA will be 1:1 randomized to routine CFT added to standard care or standard care. Routine CFT consist of three-vessel CMD assessment (by coronary physiology measurements of CFR/I

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. MINOCA diagnosis at index coronary angiography 2. At least 18 years of age 3.Oral consent for EDIT-MINOCA 4. In case of NSTEMI: High-sensitivity cardiac troponin T cut off value >52 ng/L or High-sensitivity cardiac troponin I cut off value according to the values stated in Table S4 in the 2023 ESC guidelines for the management of acute coronary syndrome

Exclusion criteria

Exclusion criteria: 1. Patients with limited life expectancy (<1 year)  2. Pregnancy, or active desire to become pregnant in the upcoming month 3. Contra-indication to cardiac magnetic resonance imaging 4. Contra-indication to intravenous adenosine 5. Previous Coronary Artery Bypass Grafting (CABG) 6. Reasonable suspicion for late gadolinium enhancement (LGE) due to previous  myocardial infarction 7. Known severe valvular heart disease  8. Severe renal dysfunction, defined as eGFR <30 mL/min/1.73 m2

Design outcomes

Primary

MeasureTime frame
The number of identified diagnoses by routine CFT plus standard care versus standard care (OCT, CMR and elective CFT)

Secondary

MeasureTime frame
To assess quality of life and angina outcomes at 12-month follow-up.Net adverse clinical events are defined as death, cardiovascular death, myocardial infarction, stroke, coronary revascularization, hospitalization for chest pain/discomfort, emergency department visits for chest pain/discomfort, transient ischemic attack, bleeding complications (BARC 2 or higher) and congestive heart failure.Major adverse cardiovascular events are defined as cardiovascular death, myocardial infarction, stroke, coronary revascularization, bleeding complications (BARC 2 or higher) and congestive heart failure.The number of correctly identified culprit vessels by physiology/OCT compared to standard diagnostic work up with CMR confirmed myocardial infarction as the gold standard. We expect to identify more CMR confirmed MI in the combined physiology plus OCT arm versus the control arm. Definitions are as follows: CMR-confirmed MI: late gadolinium enhancement with a distribution pattern consistent with myocardial infarctionCoronary physiology is considered abnormal if: CFR <2.5 and/or IMR >25 (assessed per vessel) in the infarcted area on CMR.Positive intracoronary imaging culprit defined as plaque rupture/erosion, thrombus, intra-plaque cavity, eruptive calcified nodule, or coronary dissection in the CMR-indicated infarct areaDemonstrated spasm (either microvascular spasm and/or epicardial spasm) in the coronary artery supplying the infarcted area on CMR 

Countries

Netherlands

Contacts

Public ContactB Yosofi

Radboud Universitair Medisch Centrum

behruz.yosofi@radboudumc.nl0243094135

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 23, 2026